Medicus Pharma secured an ADC development deal with Pfizer and is advancing its SkinJect 005 study for FDA approval.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Medicus Pharma secured an ADC development deal with Pfizer and is advancing its SkinJect 005 study for FDA approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- Collaboration revenue realization from Pfizer and GSK backing royalty financing for Spero Therapeutics.
- FDA granted approval for Pfizer's updated vaccine on September 2, 2025.
- Roivant Sciences licensed a drug from Pfizer for regulatory approval.
- The FDA suspended Pfizer's C&F Depot license.